Kereos' Series D Round

Kereos raised a round of funding on May 24, 2010.

Kereos develops targeted molecular imaging agents and therapeutics designed to detect and treat cancer and cardiovascular disease earlier and more specifically than currently possible. The specificity…

Articles about Kereos' Series D Round: